{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:55:39Z","timestamp":1793904939072,"version":"4.8.0"},"reference-count":487,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Statins, primarily prescribed for their lipid-lowering effects, have garnered significant attention for their potent anti-inflammatory effects. This review explores the underlying molecular pathways and clinical relevance of statins\u2019 anti-inflammatory actions, extending beyond cardiovascular disease management to chronic inflammatory conditions and oncological applications. The lipid-lowering effect of statins stems from their ability to suppress HMG-CoA reductase, a crucial enzyme in cholesterol synthesis; however, their pleiotropic effects include modulation of critical inflammatory pathways such as the inhibition of NF-\u03baB signalling, a reduction in pro-inflammatory cytokine production, and enhancement of endothelial function. We delve into the molecular pathways influenced by statins, including their effects on inflammatory mediators like C-reactive protein (CRP), interleukins (IL-6, IL-1\u03b2), and tumour necrosis factor-alpha (TNF-\u03b1). Clinical evidence supporting the efficacy of statins in managing chronic inflammatory diseases, such as rheumatoid arthritis, chronic obstructive pulmonary disease, diabetes, and osteoarthritis, is critically reviewed. Additionally, we investigate the emerging role of statins in oncology, examining their impact on inflammation-driven carcinogenesis, tumour microenvironment modulation, and cancer progression. Despite their broad therapeutic potential, the safety profile of statins, particularly concerning adverse effects such as myopathy, hepatotoxicity, and potential diabetes risk, is discussed. Controversies surrounding the extent of their anti-inflammatory benefits and the variability in patient responses are also addressed. This review consolidates the current literature, elucidating the biochemical mechanisms underlying the anti-inflammatory properties of statins and evaluating their clinical applications and associated controversies. Future research directions are identified, including the development of novel statin analogues with enhanced anti-inflammatory effects and the investigation of new therapeutic indications in inflammatory diseases and cancer. By providing an in-depth analysis, this review underscores the expanding therapeutic scope of statins and advocates for their integration into broader clinical strategies for the management of inflammation and cancer.<\/jats:p>","DOI":"10.3390\/ijms26178429","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:42:21Z","timestamp":1756485741000},"page":"8429","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-\u03baB, NLRP3 Inflammasome, and Cytokine Regulatory Axes"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5295-3901","authenticated-orcid":false,"given":"Sara","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, Umm Hurair 2, Dubai Healthcare City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5751-8424","authenticated-orcid":false,"given":"Bintul","family":"Huda","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, Umm Hurair 2, Dubai Healthcare City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3941-2504","authenticated-orcid":false,"given":"Farida","family":"Bhurka","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, Umm Hurair 2, Dubai Healthcare City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, Umm Hurair 2, Dubai Healthcare City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7546-8893","authenticated-orcid":false,"given":"Yajnavalka","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, Umm Hurair 2, Dubai Healthcare City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","unstructured":"(1994). Randomised trial of cholestesrol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383\u20131389."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group (2002). MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360, 7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"LIPID Study Group (2002). Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: The LIPID trial follow-up. Lancet, 359, 1379\u20131387. Erratum in Lancet 2002, 360, 1430.","DOI":"10.1016\/S0140-6736(02)08351-4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2009.09.010","article-title":"Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy","volume":"54","author":"Gibson","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"113C","DOI":"10.1016\/S0002-9149(99)80480-9","article-title":"The West of Scotland Coronary Prevention Study: A trial of cholesterol reduction in Scottish men","volume":"76","author":"Shepherd","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1007\/s12035-023-03371-2","article-title":"The Effect of Simvastatin on the Dynamics of NF-kappaB-Regulated Neurodegenerative and Neuroprotective Processes in the Acute Phase of Ischemic Stroke","volume":"60","author":"Lietzau","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wozniak, E., Broncel, M., Niedzielski, M., Wozniak, A., and Gorzelak-Pabis, P. (2023). The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0280741"},{"key":"ref_12","first-page":"354","article-title":"Effect of statins on endothelial function in patients with acute coronary syndrome: A prospective study using adhesion molecules and flow-mediated dilatation","volume":"6","author":"Altun","year":"2014","journal-title":"J. Clin. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Michels da Silva, D., Langer, H., and Graf, T. (2019). Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092322"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"116464","DOI":"10.1016\/j.lfs.2019.05.020","article-title":"Mitochondrial DNA in liver inflammation and oxidative stress","volume":"236","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.giec.2019.02.005","article-title":"The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?","volume":"29","author":"Fritsch","year":"2019","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Liu, W., Deng, Y., Li, Z., Chen, Y., Zhu, X., Tan, X., and Cao, G. (2021). Cancer Evo-Dev: A Theory of Inflammation-Induced Oncogenesis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.768098"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Akkiz, H., Simsek, H., Balci, D., Ulger, Y., Onan, E., Akcaer, N., and Delik, A. (2025). Inflammation and cancer: Molecular mechanisms and clinical consequences. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1564572"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e19596","DOI":"10.1097\/MD.0000000000019596","article-title":"Impact of statin use on cancer-specific mortality and recurrence: A meta-analysis of 60 observational studies","volume":"99","author":"Yang","year":"2020","journal-title":"Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zaky, M.Y., Fan, C., Zhang, H., and Sun, X.F. (2023). Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance. Cancers, 15.","DOI":"10.3390\/cancers15194787"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Khatiwada, N., and Hong, Z. (2024). Potential Benefits and Risks Associated with the Use of Statins. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16020214"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: Perception vs. the evidence\u2014Focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_24","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/jama.2013.281348","article-title":"Statin therapy for primary prevention of cardiovascular disease","volume":"310","author":"Taylor","year":"2013","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_29","first-page":"328","article-title":"HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview","volume":"22","author":"Balasubramanian","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/17425255.2020.1801634","article-title":"An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins","volume":"16","author":"Hirota","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/a-1873-1978","article-title":"Pleiotropic Benefits of Statins in Cardiovascular Diseases","volume":"72","author":"Wasim","year":"2022","journal-title":"Drug Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: Master regulators of lipid homeostasis","volume":"86","author":"Eberle","year":"2004","journal-title":"Biochimie"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12263-013-0342-x","article-title":"A pathway approach to investigate the function and regulation of SREBPs","volume":"8","author":"Daemen","year":"2013","journal-title":"Genes Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Miyata, S., Kodaka, M., Kikuchi, A., Matsunaga, Y., Shoji, K., Kuan, Y.C., Iwase, M., Takeda, K., Katsuta, R., and Ishigami, K. (2022). Sulforaphane suppresses the activity of sterol regulatory element-binding proteins (SREBPs) by promoting SREBP precursor degradation. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-12347-6"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e220019","DOI":"10.1530\/EC-22-0019","article-title":"Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia","volume":"11","author":"Chan","year":"2022","journal-title":"Endocr. Connect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: Mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: Regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5551\/jat.5405","article-title":"Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions","volume":"17","author":"Yamashita","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3i","DOI":"10.1016\/S0002-9149(03)00503-4","article-title":"The Heart Protection Study: Expanding the boundaries for high-risk coronary disease prevention","volume":"92","author":"Farmer","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3949\/ccjm.70.6.561","article-title":"The Lescol Intervention Prevention Study (LIPS): Start all patients on statins early after PCI","volume":"70","author":"Messerli","year":"2003","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14656566.2018.1544243","article-title":"An evaluation of pitavastatin for the treatment of hypercholesterolemia","volume":"20","author":"Chan","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_44","first-page":"CD012735","article-title":"Pitavastatin for lowering lipids","volume":"6","author":"Adams","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1253\/circj.CJ-12-1062","article-title":"Effects of pitavastatin in Japanese patients with chronic heart failure: The Pitavastatin Heart Failure Study (PEARL Study)","volume":"77","author":"Takano","year":"2013","journal-title":"Circ. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","article-title":"Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)","volume":"54","author":"Hiro","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.str.0000034125.94759.41","article-title":"ACC\/AHA\/NHLBI Clinical Advisory on the Use and Safety of Statins","volume":"33","author":"Pasternak","year":"2002","journal-title":"Stroke"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.12902","article-title":"Immune modulatory effects of statins","volume":"154","author":"Zeiser","year":"2018","journal-title":"Immunology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2014.02.007","article-title":"Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease","volume":"143","author":"Yeganeh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_50","first-page":"874","article-title":"Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)","volume":"83","author":"Arefieva","year":"2018","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1493684","DOI":"10.1155\/2023\/1493684","article-title":"Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression","volume":"2023","author":"Chen","year":"2023","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_52","first-page":"69","article-title":"Anti-inflammatory effects of simvastatin in nonsteroidal anti-inflammatory drugs-induced small bowel injury","volume":"68","author":"Kim","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00011-014-0794-5","article-title":"Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis","volume":"64","author":"Pathak","year":"2015","journal-title":"Inflamm. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.18632\/aging.205937","article-title":"The beneficial effects of Rosuvastatin in inhibiting inflammation in sepsis","volume":"16","author":"Tang","year":"2024","journal-title":"Aging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.3748\/wjg.v23.i25.4559","article-title":"Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model","volume":"23","author":"Shin","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2014.06.006","article-title":"Statins upregulate cystathionine gamma-lyase transcription and H2S generation via activating Akt signaling in macrophage","volume":"87","author":"Xu","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1159\/000100498","article-title":"Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events","volume":"106","author":"Gu","year":"2007","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_58","first-page":"2071","article-title":"Anti-inflammation of simvastatin by polarization of murine macrophages from M1 phenotype to M2 phenotype","volume":"93","author":"Li","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"L882","DOI":"10.1152\/ajplung.00238.2007","article-title":"Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice","volume":"294","author":"Takahashi","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jcb.23388","article-title":"Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IkappaBalpha degradation, and COX-2 expression in murine macrophages","volume":"113","author":"Shao","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.ATV.0000030360.72503.56","article-title":"Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol","volume":"22","author":"Sukhova","year":"2002","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10549-011-1858-7","article-title":"A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer","volume":"131","author":"Higgins","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-013-2739-z","article-title":"A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk","volume":"142","author":"Vinayak","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1940-6207.CAPR-13-0189","article-title":"A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology","volume":"7","author":"Linden","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/joim.12337","article-title":"Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): A randomized controlled trial","volume":"278","author":"Neukamm","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1758-5996-2-34","article-title":"Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects","volume":"2","author":"Kater","year":"2010","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1074248413489771","article-title":"Increasing doses of simvastatin versus combined ezetimibe\/simvastatin: Effect on circulating endothelial progenitor cells","volume":"18","author":"Pesaro","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"da Silva Pereira, E.N.G., Franco, R.L.C., Santos, R., and Daliry, A. (2025). Statins and non-alcoholic fatty liver disease: A concise review. Biomed. Pharmacother., 183.","DOI":"10.1016\/j.biopha.2024.117805"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-2094-10-78","article-title":"Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy","volume":"10","author":"Lappegard","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin Toxicity","volume":"124","author":"Ward","year":"2019","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.ATV.0000168410.44722.86","article-title":"Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes","volume":"25","author":"Methe","year":"2005","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/pds.3646","article-title":"Statins and the risk of liver injury: A population-based case-control study","volume":"23","author":"Chen","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2010.02.019","article-title":"High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling\u2013results from a randomized, double-blind, and placebo-controlled study","volume":"146","author":"Erbs","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Grip, O., and Janciauskiene, S. (2009). Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn\u2019s disease. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005263"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1021\/acschemneuro.3c00472","article-title":"Interplay of Cholesterol and Actin in Neurotransmitter GPCR Signaling: Insights from Chronic Cholesterol Depletion Using Statin","volume":"14","author":"Sarkar","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jacl.2009.04.052","article-title":"The SLIM Study: Slo-Niacin(R) and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia","volume":"3","author":"Knopp","year":"2009","journal-title":"J. Clin. Lipidol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2215-0366(20)30512-5","article-title":"Associations between statin use and suicidality, depression, anxiety, and seizures","volume":"8","author":"Ljung","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinthera.2011.11.002","article-title":"Long-term statin therapy in patients with systolic heart failure and normal cholesterol: Effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide","volume":"34","author":"Abulhul","year":"2012","journal-title":"Clin. Ther."},{"key":"ref_79","first-page":"MS12","article-title":"The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy","volume":"15","author":"Goch","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/ATVBAHA.110.218685","article-title":"Timing and dose of statin therapy define its impact on inflammatory and endothelial responses during myocardial infarction","volume":"31","author":"Sposito","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jjcc.2012.07.012","article-title":"Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: The PREMIUM Study","volume":"60","author":"Matsubara","year":"2012","journal-title":"J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2013-2674","article-title":"Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): A prospective, randomized, double-blind, placebo-controlled study","volume":"98","author":"Puurunen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Sena-Evangelista, K.C., Pedrosa, L.F., Paiva, M.S., Dias, P.C., Ferreira, D.Q., Cozzolino, S.M., Faulin, T.E., and Abdalla, D.S. (2015). The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: A double blind randomized controlled study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119830"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pupt.2017.03.001","article-title":"Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial","volume":"44","author":"Rossi","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_85","first-page":"1459","article-title":"Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: A pilot study","volume":"34","author":"Khanna","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2891-12-142","article-title":"Effects of coenzyme Q10 supplementation (300 mg\/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: A randomized, placebo-controlled trial","volume":"12","author":"Lee","year":"2013","journal-title":"Nutr. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-2600(14)70050-5","article-title":"Atorvastatin as a stable treatment in bronchiectasis: A randomised controlled trial","volume":"2","author":"Mandal","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_88","first-page":"423120","article-title":"Response to statin therapy in obstructive sleep apnea syndrome: A multicenter randomized controlled trial","volume":"2014","author":"Tamisier","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/COPD.S76061","article-title":"Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: A randomized controlled trial","volume":"10","author":"John","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.schres.2014.08.021","article-title":"A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: Effect on inflammation, psychopathology, cognition and lipid metabolism","volume":"159","author":"Vincenzi","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1164\/rccm.200904-0501OC","article-title":"[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation","volume":"180","author":"Chen","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1540-8167.2010.01925.x","article-title":"Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)","volume":"22","author":"Negi","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jvs.2014.06.116","article-title":"Association of monocyte tumor necrosis factor alpha expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease","volume":"61","author":"Pande","year":"2015","journal-title":"J. Vasc. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jacc.2009.03.018","article-title":"The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease","volume":"53","author":"Tang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1093\/rheumatology\/keaa190","article-title":"Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: The RORA-AS statin intervention study","volume":"59","author":"Os","year":"2020","journal-title":"Rheumatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e000544","DOI":"10.1136\/rmdopen-2017-000544","article-title":"Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases","volume":"3","author":"Svanteson","year":"2017","journal-title":"RMD Open"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ikdahl, E., Rollefstad, S., Hisdal, J., Olsen, I.C., Pedersen, T.R., Kvien, T.K., and Semb, A.G. (2016). Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153440"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13075-015-0795-y","article-title":"Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: Results from the RORA-AS statin intervention study","volume":"17","author":"Ikdahl","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.39114","article-title":"Rosuvastatin-Induced Carotid Plaque Regression in Patients with Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study","volume":"67","author":"Rollefstad","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCULATIONAHA.112.095554","article-title":"Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2","volume":"126","author":"Pignatelli","year":"2012","journal-title":"Circulation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2006.11.046","article-title":"Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome","volume":"49","author":"Tahara","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jacc.2006.03.069","article-title":"Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography","volume":"48","author":"Tahara","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2015.03.039","article-title":"The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial","volume":"240","author":"Emami","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4103\/ijccm.IJCCM_474_16","article-title":"The Effects of Atorvastatin on Inflammatory Responses and Mortality in Septic Shock: A Single-center, Randomized Controlled Trial","volume":"21","author":"Singh","year":"2017","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, Truwit, J.D., Bernard, G.R., Steingrub, J., Matthay, M.A., Liu, K.D., Albertson, T.E., Brower, R.G., Shanholtz, C., and Rock, P. (2014). Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N. Engl. J. Med., 370, 2191\u20132200.","DOI":"10.1056\/NEJMoa1401520"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-2600(16)00005-9","article-title":"Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: An ancillary study to a randomised controlled trial","volume":"4","author":"Needham","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/thoraxjnl-2015-208017","article-title":"One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: Prospective follow-up of SAILS randomised trial","volume":"71","author":"Dinglas","year":"2016","journal-title":"Thorax"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5847\/wjem.j.1920-8642.2022.072","article-title":"Is rosuvastatin protective against sepsis-associated encephalopathy? A secondary analysis of the SAILS trial","volume":"13","author":"Yu","year":"2022","journal-title":"World J. Emerg. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.2010.08480.x","article-title":"A pilot study of the short-term use of simvastatin in sickle cell disease: Effects on markers of vascular dysfunction","volume":"153","author":"Hoppe","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Braganza, G., Chaudhuri, R., McSharry, C., Weir, C.J., Donnelly, I., Jolly, L., Lafferty, J., Lloyd, S.M., Spears, M., and Mair, F. (2011). Effects of short-term treatment with atorvastatin in smokers with asthma\u2014A randomized controlled trial. BMC Pulm. Med., 11.","DOI":"10.1186\/1471-2466-11-16"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chest.2017.05.017","article-title":"A Randomized Controlled Trial of Atorvastatin in Patients with Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study","volume":"152","author":"Bedi","year":"2017","journal-title":"Chest"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.numecd.2020.10.002","article-title":"Effect of atorvastatin on lipogenic, inflammatory and thrombogenic markers in women with the metabolic syndrome","volume":"31","author":"Velarde","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/cc10343","article-title":"Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock","volume":"15","author":"Donnino","year":"2011","journal-title":"Crit. Care"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11420-017-9577-1","article-title":"Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients","volume":"14","author":"Bass","year":"2018","journal-title":"HSS J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2459\/JCM.0b013e3282f447c3","article-title":"Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy","volume":"9","author":"Gottlieb","year":"2008","journal-title":"J. Cardiovasc. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: A randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAI.0000000000001644","article-title":"Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living with HIV","volume":"78","author":"deFilippi","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2016.10.029","article-title":"Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study","volume":"69","author":"Kini","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12630-012-9702-z","article-title":"STAR VaS\u2013Short Term Atorvastatin Regime for Vasculopathic Subjects: A randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery","volume":"59","author":"Neilipovitz","year":"2012","journal-title":"Can. J. Anaesth."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cct.2019.05.011","article-title":"Hellenic Postprandial Lipemia Study (HPLS): Rationale and design of a prospective, open-label trial to determinate the prevalence of abnormal postprandial lipemia as well as its interaction with statins in patients at high- and very high-risk for cardiovascular disease","volume":"82","author":"Kolovou","year":"2019","journal-title":"Contemp. Clin. Trials"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Negredo, E., Jimenez, M., Puig, J., Loste, C., Perez-Alvarez, N., Urrea, V., Echeverria, P., Bonjoch, A., Clotet, B., and Blanco, J. (2020). A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238575"},{"key":"ref_122","first-page":"844","article-title":"Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals","volume":"72","author":"Negredo","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s00213-022-06156-y","article-title":"An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers","volume":"239","author":"Quinton","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"jcs248344","DOI":"10.1242\/jcs.248344","article-title":"Recent insights into the regulatory networks of NLRP3 inflammasome activation","volume":"133","author":"Weber","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"154215","DOI":"10.1016\/j.cyto.2017.11.009","article-title":"IL-1 family cytokines in cardiovascular disease","volume":"122","author":"Pfeiler","year":"2019","journal-title":"Cytokine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2005.06.019","article-title":"Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells","volume":"185","author":"Holschermann","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jacc.2014.01.054","article-title":"Innate and adaptive inflammation as a therapeutic target in vascular disease: The emerging role of statins","volume":"63","author":"Tousoulis","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory Action of Statins in Cardiovascular Disease: The Role of Inflammasome and Toll-Like Receptor Pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1189\/jlb.0812409","article-title":"HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation","volume":"93","author":"Liao","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Antonello, J., and Roy, P. (2025). Damage-associated molecular patterns (DAMPs) in vascular diseases. J. Biol. Chem., 301.","DOI":"10.1016\/j.jbc.2025.110241"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"14008","DOI":"10.3390\/ijms140714008","article-title":"Toll-like receptors in atherosclerosis","volume":"14","author":"Kassiteridi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Jannati, S., Patel, A., Patnaik, R., and Banerjee, Y. (2025). Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125521"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Kusiak, A., and Brady, G. (2022). Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation. Biochem. Pharmacol., 205.","DOI":"10.1016\/j.bcp.2022.115246"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.fjc.0000159042.50488.e5","article-title":"HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells","volume":"45","author":"Ortego","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Mylonas, K.S., Peroulis, M., Schizas, D., and Kapelouzou, A. (2023). MYD88 and Proinflammatory Chemokines in Aortic Atheromatosis: Exploring Novel Statin Effects. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119248"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/mol.116.108100","article-title":"Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNFalpha in Vascular Endothelial Cells through a PXR-Dependent Mechanism","volume":"92","author":"Wang","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jpp\/rgae024","article-title":"Regulatory impact of statins on macrophage polarization: Mechanistic and therapeutic implications","volume":"76","author":"Sadeghi","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Menini, S., Iacobini, C., Vitale, M., and Pugliese, G. (2020). The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. Cells, 9.","DOI":"10.3390\/cells9081812"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41419-019-2109-9","article-title":"The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation","volume":"10","author":"Fu","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12959-021-00299-2","article-title":"Differential effect of statin use on coagulation markers: An active comparative analysis in the NEO study","volume":"19","author":"Bordbar","year":"2021","journal-title":"Thromb. J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41419-021-03389-1","article-title":"Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s10020-024-01025-0","article-title":"The pleiotropic effects of statins: A comprehensive exploration of neurovascular unit modulation and blood-brain barrier protection","volume":"30","author":"Liu","year":"2024","journal-title":"Mol. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effects","volume":"97","author":"German","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BST20130267","article-title":"Regulation of IL-6-type cytokine responses by MAPKs","volume":"42","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.injury.2015.03.028","article-title":"N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1\/2 and P38 MAP kinase signalling pathways","volume":"46","author":"Hazeldine","year":"2015","journal-title":"Injury"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00125.2020","article-title":"Statins activate the NLRP3 inflammasome and impair insulin signaling via p38 and mTOR","volume":"319","author":"Henriksbo","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.2174\/1381612823666171009141201","article-title":"Statins and inflammation in cardiovascular disease","volume":"23","author":"Vogiatzi","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11883-021-00977-6","article-title":"Statins and Inflammation","volume":"23","author":"Satny","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"eadh2381","DOI":"10.1126\/scisignal.adh2381","article-title":"The kinase ITK controls a Ca2+-mediated switch that balances T(H)17 and T(reg) cell differentiation","volume":"17","author":"Anannya","year":"2024","journal-title":"Sci. Signal."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Prado, D.S., Cattley, R.T., Shipman, C.W., Happe, C., Lee, M., Boggess, W.C., MacDonald, M.L., and Hawse, W.F. (2021). Synergistic and additive interactions between receptor signaling networks drive the regulatory T cell versus T helper 17 cell fate choice. J. Biol. Chem., 297.","DOI":"10.1016\/j.jbc.2021.101330"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/imr.12199","article-title":"Complex interactions of transcription factors in mediating cytokine biology in T cells","volume":"261","author":"Li","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/eji.202048794","article-title":"Transcriptional and posttranslational regulation of Th17\/Treg balance in health and disease","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-beta signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"6309219","DOI":"10.1155\/2016\/6309219","article-title":"Balancing Inflammation: The Link between Th17 and Regulatory T Cells","volume":"2016","author":"Diller","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxp021","article-title":"Th17 cells: From precursors to players in inflammation and infection","volume":"21","author":"Awasthi","year":"2009","journal-title":"Int. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Miller, S., Eizenberg-Magar, I., Reich-Zeliger, S., Rimer, J., Zaretsky, I., Reshef, D., Kopitman, E., Friedman, N., and Antebi, Y.E. (2025). Independent and temporally separated dynamics for RORgammat and Foxp3 during Th17 differentiation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1462045"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Le Menn, G., Jablonska, A., and Chen, Z. (2022). The effects of post-translational modifications on Th17\/Treg cell differentiation. Biochim. Biophys. Acta Mol. Cell Res., 1869.","DOI":"10.1016\/j.bbamcr.2022.119223"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.4049\/jimmunol.181.5.3524","article-title":"Statins induce regulatory T cell recruitment via a CCL1 dependent pathway","volume":"181","author":"Mira","year":"2008","journal-title":"J. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-019-09089-5","article-title":"On the immunoregulatory role of statins in multiple sclerosis: The effects on Th17 cells","volume":"67","author":"Ntolkeras","year":"2019","journal-title":"Immunol. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2014.03.001","article-title":"Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases","volume":"88","author":"Ulivieri","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-065X.2007.00536.x","article-title":"Integrin modulation and signaling in leukocyte adhesion and migration","volume":"218","author":"Rose","year":"2007","journal-title":"Immunol. Rev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: The leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajpath.2013.12.033","article-title":"How endothelial cells regulate transmigration of leukocytes in the inflammatory response","volume":"184","author":"Muller","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"107614","DOI":"10.1016\/j.pharmthera.2020.107614","article-title":"Statins and autoimmunity: State-of-the-art","volume":"214","author":"Dehnavi","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMra2206346","article-title":"Humoral Innate Immunity and Acute-Phase Proteins","volume":"388","author":"Mantovani","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-94-024-0921-5_2","article-title":"The Interleukin-1 Family","volume":"941","author":"Yazdi","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Pyrillou, K., Burzynski, L.C., and Clarke, M.C.H. (2020). Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.613170"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e20190314","DOI":"10.1084\/jem.20190314","article-title":"Inflammasome signaling and regulation of interleukin-1 family cytokines","volume":"217","author":"Chan","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Kany, S., Vollrath, J.T., and Relja, B. (2019). Cytokines in Inflammatory Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236008"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.molimm.2007.12.017","article-title":"Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C\/EBPbeta-dependent autocrine interleukin-6 loop","volume":"45","author":"Kramer","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/10409238.2018.1458070","article-title":"Isoprenoids and protein prenylation: Implications in the pathogenesis and therapeutic intervention of Alzheimer\u2019s disease","volume":"53","author":"Jeong","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","article-title":"Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition","volume":"6","author":"Hameed","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.bbadis.2018.08.034","article-title":"Type 2 diabetes\u2014An autoinflammatory disease driven by metabolic stress","volume":"1864","author":"Gonzalez","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejcb.2015.12.002","article-title":"GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction","volume":"95","author":"Li","year":"2016","journal-title":"Eur. J. Cell Biol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-010-0460-1","article-title":"RhoA\/Rho-kinase and vascular diseases: What is the link?","volume":"67","author":"Nunes","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2008.12.040","article-title":"RhoA induces expression of inflammatory cytokine in adipocytes","volume":"379","author":"Nakayama","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2337\/db12-1148","article-title":"Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle","volume":"62","author":"Sylow","year":"2013","journal-title":"Diabetes"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/ATVBAHA.112.300922","article-title":"Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation","volume":"33","author":"Tanaka","year":"2013","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00125-007-0597-0","article-title":"A novel mechanism of action for statins against diabetes-induced oxidative stress","volume":"50","author":"Vecchione","year":"2007","journal-title":"Diabetologia"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Bruder-Nascimento, T., Callera, G., Montezano, A.C., Antunes, T.T., He, Y., Cat, A.N., Ferreira, N.S., Barreto, P.A., Olivon, V.C., and Tostes, R.C. (2016). Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt\/GSK3. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162731"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-kappaB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/er.2007-0015","article-title":"The role for endoplasmic reticulum stress in diabetes mellitus","volume":"29","author":"Eizirik","year":"2008","journal-title":"Endocr. Rev."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Suryavanshi, S.V., and Kulkarni, Y.A. (2017). NF-kappabeta: A Potential Target in the Management of Vascular Complications of Diabetes. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00798"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"176699","DOI":"10.1016\/j.ejphar.2024.176699","article-title":"Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling","volume":"976","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.12659\/MSM.913244","article-title":"Simvastatin Improves Cardiac Hypertrophy in Diabetic Rats by Attenuation of Oxidative Stress and Inflammation Induced by Calpain-1-Mediated Activation of Nuclear Factor-kappaB (NF-kappaB)","volume":"25","author":"Han","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Lin, C.P., Huang, P.H., Lai, C.F., Chen, J.W., Lin, S.J., and Chen, J.S. (2015). Simvastatin Attenuates Oxidative Stress, NF-kappaB Activation, and Artery Calcification in LDLR-\/- Mice Fed with High Fat Diet via Down-regulation of Tumor Necrosis Factor-alpha and TNF Receptor 1. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143686"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-025-02683-y","article-title":"Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation","volume":"24","author":"Bosco","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.numecd.2020.11.009","article-title":"Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience","volume":"31","author":"Scicali","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s11096-024-01754-6","article-title":"Causal impact of statins on susceptibility to osteoarthritis: Insights from a two-sample Mendelian randomization analysis","volume":"46","author":"Yu","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Chen, W., Sun, Z., Xiong, X., Tan, H., Hu, J., Liu, C., and Chen, C. (2024). Exploring the causal link among statin drugs and the osteoarthritis risk based on Mendelian randomization research. Front. Genet., 15.","DOI":"10.3389\/fgene.2024.1390387"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31138\/mjr.32.3.227","article-title":"Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review","volume":"32","author":"Heidari","year":"2021","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"182097","DOI":"10.5402\/2012\/182097","article-title":"An assessment of the chondroprotective effects of intra-articular application of statin and tetracycline on early-stage experimental osteoarthritis","volume":"2012","author":"Dinc","year":"2012","journal-title":"ISRN Orthop."},{"key":"ref_202","first-page":"205","article-title":"Anabolic and destructive mediators in osteoarthritis","volume":"3","year":"2000","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_203","first-page":"463","article-title":"Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"33","author":"Yokota","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_204","first-page":"696","article-title":"Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients","volume":"25","author":"Lazzerini","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: Exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/ibd\/izad105","article-title":"Pro-inflammatory Cytokines Promote the Occurrence and Development of Colitis-associated Colorectal Cancer by Inhibiting miR-615-5p","volume":"29","author":"Sun","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Florescu, D.N., Boldeanu, M.V., Serban, R.E., Florescu, L.M., Serbanescu, M.S., Ionescu, M., Streba, L., Constantin, C., and Vere, C.C. (2023). Correlation of the Pro-Inflammatory Cytokines IL-1beta, IL-6, and TNF-alpha, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer. Life, 13.","DOI":"10.3390\/life13122261"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800911795538066","article-title":"Cytokines, inflammation and colon cancer","volume":"11","author":"Klampfer","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Shibabaw, T., Teferi, B., and Ayelign, B. (2023). The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1094823"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., and Delort, L. (2023). Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044002"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"7785890","DOI":"10.1155\/2021\/7785890","article-title":"Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling","volume":"2021","author":"Liu","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Diep, S., Maddukuri, M., Yamauchi, S., Geshow, G., and Delk, N.A. (2022). Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance. Cells, 11.","DOI":"10.3390\/cells11101673"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-3083.2003.01205.x","article-title":"Cytokines in patients with lung cancer","volume":"57","author":"Matanic","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Silva, E.M., Mariano, V.S., Pastrez, P.R.A., Pinto, M.C., Castro, A.G., Syrjanen, K.J., and Longatto-Filho, A. (2017). High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181125"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.7314\/APJCP.2013.14.8.4765","article-title":"Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer","volume":"14","author":"Song","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: From threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vph.2011.03.002","article-title":"Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC","volume":"54","author":"Bergman","year":"2011","journal-title":"Vasc. Pharmacol."},{"key":"ref_218","first-page":"141","article-title":"IL-6 and IL-8 responses of colorectal cancer in vivo and in vitro cancer cells subjected to simvastatin","volume":"60","author":"Malicki","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Dang, Y., Zhang, Y., and Wang, Z. (2025). The role of statins in the regulation of breast and colorectal cancer and future directions. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1578345"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Liu, S., Uppal, H., Demaria, M., Desprez, P.Y., Campisi, J., and Kapahi, P. (2015). Simvastatin suppresses breast cancer cell proliferation induced by senescent cells. Sci. Rep., 5.","DOI":"10.1038\/srep17895"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2020.05.005","article-title":"Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins","volume":"484","author":"Galland","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Gallelli, L., Falcone, D., Scaramuzzino, M., Pelaia, G., D\u2019Agostino, B., Mesuraca, M., Terracciano, R., Spaziano, G., Maselli, R., and Navarra, M. (2014). Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide. BMC Pharmacol. Toxicol., 15.","DOI":"10.1186\/2050-6511-15-67"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2249.2012.04564.x","article-title":"Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells","volume":"168","author":"Iwata","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Sabeel, S., Motaung, B., Nguyen, K.A., Ozturk, M., Mukasa, S.L., Wolmarans, K., Blom, D.J., Sliwa, K., Nepolo, E., and Gunther, G. (2025). Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0323749"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Jeong, G.H., Lee, K.H., Kim, J.Y., Eisenhut, M., Kronbichler, A., van der Vliet, H.J., Hong, S.H., Shin, J.I., and Gamerith, G. (2019). Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060819"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: A meta-analysis","volume":"295","author":"Dale","year":"2006","journal-title":"JAMA"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Jiao, Z., Liu, Y., Devreotes, P.N., and Zhang, Z. (2023). The effects of statins in patients with advanced-stage cancers\u2014A systematic review and meta-analysis. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1234713"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wang, X., Tian, W., Wang, T., Jia, J., Lai, R., Wang, T., Zhang, Z., Song, L., and Ju, J. (2022). The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-analysis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.936817"},{"key":"ref_230","first-page":"4","article-title":"Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]","volume":"6","author":"Ostadal","year":"2005","journal-title":"CuZrr. Control Trials Cardiovasc. Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.ejca.2014.08.005","article-title":"Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study","volume":"50","author":"Kim","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-10-2525","article-title":"A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer","volume":"17","author":"Han","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4143\/crt.2016.546","article-title":"Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"4174395","DOI":"10.1155\/2020\/4174395","article-title":"A Prospective, Randomized, Placebo-Controlled Study of a Combination of Simvastatin and Chemotherapy in Metastatic Breast Cancer","volume":"2020","author":"Alarfi","year":"2020","journal-title":"J. Oncol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41467-024-48441-8","article-title":"Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression","volume":"15","author":"Park","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14740338.2022.1988568","article-title":"Inclisiran: A small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia","volume":"21","author":"Banerjee","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_237","first-page":"25","article-title":"Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field","volume":"27","author":"Andreychuk","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Li, J., Niu, Q., Wu, A., Zhang, Y., Hong, L., and Wang, H. (2023). Causal relationship between circulating immune cells and the risk of type 2 diabetes: A Mendelian randomization study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1210415"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"L71","DOI":"10.1152\/ajplung.00547.2017","article-title":"Th1 cytokines TNF-alpha and IFN-gamma promote corticosteroid resistance in developing human airway smooth muscle","volume":"316","author":"Britt","year":"2019","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic beta-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress","volume":"14","author":"Dludla","year":"2023","journal-title":"World J. Diabetes"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-1","article-title":"Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease","volume":"13","author":"Madhumitha","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.atherosclerosis.2005.08.013","article-title":"Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation","volume":"186","author":"Coward","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.RES.0000101298.76864.14","article-title":"Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development","volume":"93","author":"Uehara","year":"2003","journal-title":"Circ. Res."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2005.11.007","article-title":"Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors","volume":"119","author":"Brumeanu","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Espinosa-Carrasco, G., Le Saout, C., Fontanaud, P., Stratmann, T., Mollard, P., Schaeffer, M., and Hernandez, J. (2017). CD4(+) T Helper Cells Play a Key Role in Maintaining Diabetogenic CD8(+) T Cell Function in the Pancreas. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.02001"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Matoba, K., Sekiguchi, K., Nagai, Y., Yokota, T., Utsunomiya, K., and Nishimura, R. (2020). Endothelial Dysfunction in Diabetes. Biomedicines, 8.","DOI":"10.3390\/biomedicines8070182"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Muffova, B., Kauerova, S., Paukner, K., Bartuskova, H., Poledne, R., and Kralova Lesna, I. (2025). Anti-inflammatory effect of fluvastatin on polarized macrophages and its dependence on the mevalonate pathway. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-02418-9"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2119\/molmed.2011.00471","article-title":"Statins induce the accumulation of regulatory T cells in atherosclerotic plaque","volume":"18","author":"Meng","year":"2012","journal-title":"Mol. Med."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","article-title":"The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells","volume":"197","author":"Luboshits","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Liberale, L., Carbone, F., Montecucco, F., and Sahebkar, A. (2020). Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms. Int. J. Biochem. Cell Biol., 122.","DOI":"10.1016\/j.biocel.2020.105735"},{"key":"ref_251","first-page":"762506","article-title":"Statins increase the frequency of circulating CD4+ FOXP3+ regulatory T cells in healthy individuals","volume":"2015","author":"Montoya","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/os.14302","article-title":"Macrophage Polarization in the Osteoarthritis Pathogenesis and Treatment","volume":"17","author":"Zou","year":"2025","journal-title":"Orthop. Surg."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Wen, Z., Qiu, L., Ye, Z., Tan, X., Xu, X., Lu, M., and Kuang, G. (2024). The role of Th\/Treg immune cells in osteoarthritis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1393418"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: From protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2353\/ajpath.2010.090608","article-title":"Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages","volume":"177","author":"Fujita","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Alkakhan, W., Farrar, N., Sikora, V., Emecen-Huja, P., Huja, S.S., Yilmaz, O., and Pandruvada, S.N. (2023). Statins Modulate Microenvironmental Cues Driving Macrophage Polarization in Simulated Periodontal Inflammation. Cells, 12.","DOI":"10.3390\/cells12151961"},{"key":"ref_257","first-page":"167086","article-title":"Statins as modulators of regulatory T-cell biology","volume":"2013","author":"Gutierrez","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Rajput, A., Jin, N., and Wang, J. (2020). Mechanisms of Immunosuppression in Colorectal Cancer. Cancers, 12.","DOI":"10.3390\/cancers12123850"},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"He, R., Huang, S., Lu, J., Su, L., Gao, X., and Chi, H. (2024). Unveiling the immune symphony: Decoding colorectal cancer metastasis through immune interactions. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1362709"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4251\/wjgo.v16.i5.1690","article-title":"Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies","volume":"16","author":"Nie","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"2205168","DOI":"10.1080\/07853890.2023.2205168","article-title":"The regulatory network of the chemokine CCL5 in colorectal cancer","volume":"55","author":"Zhang","year":"2023","journal-title":"Ann. Med."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Wang, F., Wang, S., and Zhou, Q. (2020). The Resistance Mechanisms of Lung Cancer Immunotherapy. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.568059"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"35752","DOI":"10.18632\/oncotarget.26293","article-title":"Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease","volume":"9","author":"Dawah","year":"2018","journal-title":"Oncotarget"},{"key":"ref_265","first-page":"1","article-title":"The Role of Cholesterol Absorption in Modulating the Immune Response in Colorectal Cancer","volume":"20","author":"Williams","year":"2024","journal-title":"Immunome Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"pkz101","DOI":"10.1093\/jncics\/pkz101","article-title":"Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung Adenocarcinoma","volume":"4","author":"Baena","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"e161940","DOI":"10.1172\/jci.insight.161940","article-title":"Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Mao","year":"2022","journal-title":"JCI Insight"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12944-023-01807-1","article-title":"Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy","volume":"22","author":"Qiao","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1097\/JS9.0000000000001582","article-title":"Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer","volume":"110","author":"Li","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2522\/ptj.20080008","article-title":"Diabetes-related microvascular and macrovascular diseases in the physical therapy setting","volume":"88","author":"Cade","year":"2008","journal-title":"Phys. Ther."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/1566524023666220922114701","article-title":"Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications","volume":"23","author":"Plowman","year":"2023","journal-title":"Curr. Mol. Med."},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Meza, C.A., La Favor, J.D., Kim, D.H., and Hickner, R.C. (2019). Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153775"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","article-title":"Nitric Oxide and Endothelial Dysfunction","volume":"36","author":"Cyr","year":"2020","journal-title":"Crit. Care Clin."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site","volume":"108","author":"Du","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/db23-0070","article-title":"Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice","volume":"72","author":"Luo","year":"2023","journal-title":"Diabetes"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/ATVBAHA.110.210500","article-title":"Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway","volume":"30","author":"Ota","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.104.511964","article-title":"Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy","volume":"112","author":"Ii","year":"2005","journal-title":"Circulation"},{"key":"ref_279","first-page":"65","article-title":"Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes","volume":"66","author":"Mason","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1476-5381.2011.01416.x","article-title":"Rosuvastatin improves endothelial function in db\/db mice: Role of angiotensin II type 1 receptors and oxidative stress","volume":"164","author":"Tian","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.175.1.531","article-title":"TNF-related activation-induced cytokine enhances leukocyte adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells","volume":"175","author":"Min","year":"2005","journal-title":"J. Immunol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/00006450-199602000-00001","article-title":"Adhesion molecules\u2013their role in health and disease","volume":"39","author":"Etzioni","year":"1996","journal-title":"Pediatr. Res."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2337\/db07-0250","article-title":"Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women","volume":"56","author":"Song","year":"2007","journal-title":"Diabetes"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/01.ATV.0000059384.34874.F0","article-title":"Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients","volume":"23","author":"Prager","year":"2003","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2007.08.013","article-title":"Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus","volume":"122","author":"Nomura","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1464-5491.2004.01382.x","article-title":"Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria","volume":"22","author":"Dogra","year":"2005","journal-title":"Diabet. Med."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.ATV.0000054659.72231.A1","article-title":"HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells","volume":"23","author":"Hattori","year":"2003","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.atherosclerosis.2007.10.003","article-title":"Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus","volume":"198","author":"Wenzel","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1161\/01.CIR.0000164260.82417.3F","article-title":"Simvastatin versus ezetimibe: Pleiotropic and lipid-lowering effects on endothelial function in humans","volume":"111","author":"Landmesser","year":"2005","journal-title":"Circulation"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"107480","DOI":"10.1016\/j.jdiacomp.2019.107480","article-title":"Therapeutic lifestyle change intervention improved metabolic syndrome criteria and is complementary to amlodipine\/atorvastatin","volume":"34","author":"Sallam","year":"2020","journal-title":"J. Diabetes Complicat."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41584-025-01223-y","article-title":"The role of the immune system in osteoarthritis: Mechanisms, challenges and future directions","volume":"21","author":"Moulin","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/rheumatology\/kev270","article-title":"High systemic levels of low-density lipoprotein cholesterol: Fuel to the flames in inflammatory osteoarthritis?","volume":"55","year":"2016","journal-title":"Rheumatology"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","article-title":"Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications","volume":"18","author":"Fearon","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Aleksandrowicz, M., Konop, M., Rybka, M., Mazurek, L., Stradczuk-Mazurek, M., Kciuk, M., Badzynska, B., Dobrowolski, L., and Kuczeriszka, M. (2025). Dysfunction of Microcirculation in Atherosclerosis: Implications of Nitric Oxide, Oxidative Stress, and Inflammation. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136467"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar2019","article-title":"Statin-induced expression of CD59 on vascular endothelium in hypoxia: A potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis","volume":"8","author":"Kinderlerer","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/hc0602.103393","article-title":"Statins have biphasic effects on angiogenesis","volume":"105","author":"Weis","year":"2002","journal-title":"Circulation"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2174\/1381612827666210303143442","article-title":"Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation","volume":"27","author":"Malhab","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4251\/wjgo.v11.i11.946","article-title":"Endothelial cells in colorectal cancer","volume":"11","author":"Chen","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Ghiabi, P., Jiang, J., Pasquier, J., Maleki, M., Abu-Kaoud, N., Rafii, S., and Rafii, A. (2014). Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112424"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1096\/fba.2022-00002","article-title":"Elevated serum Cripto-1 and VEGF levels in patients with non-small cell lung cancer","volume":"4","author":"Xu","year":"2022","journal-title":"FASEB BioAdvances"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/156800905774932824","article-title":"Anti-angiogenic and anti-inflammatory effects of statins: Relevance to anti-cancer therapy","volume":"5","author":"Dulak","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2014.283","article-title":"Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90alpha in human colorectal cancer","volume":"111","author":"Lee","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"e036411","DOI":"10.1161\/JAHA.124.036411","article-title":"Statin Therapy Reduces Radiation-Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy","volume":"13","author":"Huang","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molonc.2011.11.003","article-title":"Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production","volume":"6","author":"Chen","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Meyers, A.K., and Zhu, X. (2020). The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging. Cells, 9.","DOI":"10.3390\/cells9081808"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-024-06306-1","article-title":"Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity","volume":"68","author":"Meier","year":"2025","journal-title":"Diabetologia"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10787-024-01629-2","article-title":"Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis","volume":"33","author":"Karmakar","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_311","first-page":"571","article-title":"NLRP3 Inflammasome Activation in MPhis-CRC Crosstalk Promotes Colorectal Cancer Metastasis","volume":"52","author":"Zhang","year":"2022","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3892\/or.2016.4569","article-title":"Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells","volume":"35","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_313","first-page":"86","article-title":"Effect of NLRP3 Inflammasome on Lung Cancer Immune Microenvironment Activation and Its Mechanism","volume":"30","author":"Li","year":"2024","journal-title":"Altern. Ther. Health Med."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/s41467-019-12370-8","article-title":"NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis","volume":"10","author":"Ershaid","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"91291","DOI":"10.18632\/oncotarget.20443","article-title":"Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","article-title":"Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model","volume":"28","author":"Luo","year":"2014","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2741\/4807","article-title":"Simvastatin improves lysosome function via enhancing lysosome biogenesis in endothelial cells","volume":"25","author":"Zhang","year":"2020","journal-title":"Front. Biosci."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications","volume":"13","author":"Wondmkun","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/db12-1039","article-title":"PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Thongnak, L., Pengrattanachot, N., Promsan, S., Phengpol, N., Sutthasupha, P., Chatsudthipong, V., and Lungkaphin, A. (2022). The combination of dapagliflozin and statins ameliorates renal injury through attenuating the activation of inflammasome-mediated autophagy in insulin-resistant rats. J. Biochem. Mol. Toxicol., 36.","DOI":"10.1002\/jbt.22978"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.2337\/db13-1398","article-title":"Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance","volume":"63","author":"Henriksbo","year":"2014","journal-title":"Diabetes"},{"key":"ref_322","first-page":"1826","article-title":"NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin","volume":"20","author":"Zhu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","article-title":"NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins","volume":"26","author":"Altaf","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1080\/15384101.2021.1973707","article-title":"Atorvastatin inhibited TNF-alpha induced matrix degradation in rat nucleus pulposus cells by suppressing NLRP3 inflammasome activity and inducing autophagy through NF-kappaB signaling","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/rccm.201108-1574OC","article-title":"Statins and pulmonary fibrosis: The potential role of NLRP3 inflammasome activation","volume":"185","author":"Xu","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_326","doi-asserted-by":"crossref","unstructured":"Saber, S., Abd El-Fattah, E.E., Yahya, G., Gobba, N.A., Maghmomeh, A.O., Khodir, A.E., Mourad, A.A.E., Saad, A.S., Mohammed, H.G., and Nouh, N.A. (2021). A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP\/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals, 14.","DOI":"10.3390\/ph14040341"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.5114\/aoms\/141155","article-title":"Statins as anti-pyroptotic agents","volume":"17","author":"Khalifeh","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood-2015-11-636472","article-title":"Protease-activated receptors in hemostasis","volume":"128","author":"Nieman","year":"2016","journal-title":"Blood"},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Kagota, S., Maruyama, K., and McGuire, J.J. (2016). Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review. Biomed Res. Int., 2016.","DOI":"10.1155\/2016\/3130496"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1074\/jbc.M115.692640","article-title":"Protease-activated Receptor-2 (PAR-2)-mediated Nf-kappaB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma","volume":"291","author":"Johnson","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1161\/ATVBAHA.116.307883","article-title":"Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy","volume":"36","author":"Oe","year":"2016","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Bagang, N., Gupta, K., Singh, G., Kanuri, S.H., and Mehan, S. (2023). Protease-activated receptors in kidney diseases: A comprehensive review of pathological roles, therapeutic outcomes and challenges. Chem. Biol. Interact., 377.","DOI":"10.1016\/j.cbi.2023.110470"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1538-7836.2011.04366.x","article-title":"Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro","volume":"9","author":"Banfi","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1002\/art.22935","article-title":"Role of protease-activated receptor 2 in joint inflammation","volume":"56","author":"Lam","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.33323","article-title":"Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis","volume":"64","author":"Xue","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_336","doi-asserted-by":"crossref","unstructured":"Patnaik, R., Riaz, S., Sivani, B.M., Faisal, S., Naidoo, N., Rizzo, M., and Banerjee, Y. (2023). Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0290739"},{"key":"ref_337","doi-asserted-by":"crossref","unstructured":"Jannati, S., Patnaik, R., and Banerjee, Y. (2024). Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202406.1367.v1"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1186\/ar2329","article-title":"Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: A basic science study","volume":"9","author":"Boileau","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_339","doi-asserted-by":"crossref","unstructured":"Patnaik, R., Varghese, R., Jannati, S., Naidoo, N., and Banerjee, Y. (2024). Targeting PAR2-mediated inflammation in osteoarthritis: A comprehensive in vitro evaluation of oleocanthal\u2019s potential as a functional food intervention for chondrocyte protection and anti-inflammatory effects. BMC Musculoskelet. Disord., 25.","DOI":"10.1186\/s12891-024-07888-y"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10555-015-9599-4","article-title":"Protease-activated receptors (PARs)\u2013biology and role in cancer invasion and metastasis","volume":"34","author":"Wojtukiewicz","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/anticanres.16782","article-title":"Proteinase-activated Receptor 2: Springboard of Tumors","volume":"44","author":"Vetvicka","year":"2024","journal-title":"Anticancer Res."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s12079-023-00791-6","article-title":"Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells","volume":"17","author":"Shah","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-05-1735","article-title":"Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells","volume":"66","author":"Morris","year":"2006","journal-title":"Cancer Res."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.62347\/STSI5751","article-title":"PAR2 promotes malignancy in lung adenocarcinoma","volume":"16","author":"Wang","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.21037\/tcr-24-1027","article-title":"Targeting PAR-2-driven inflammatory pathways in colorectal cancer: Mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models","volume":"14","author":"Patnaik","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11154-023-09850-0","article-title":"An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications","volume":"25","author":"Ghesmati","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s11010-022-04398-0","article-title":"The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia","volume":"477","author":"Joshi","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"ref_348","doi-asserted-by":"crossref","unstructured":"Pare, M., Darini, C.Y., Yao, X., Chignon-Sicard, B., Rekima, S., Lachambre, S., Virolle, V., Aguilar-Mahecha, A., Basik, M., and Dani, C. (2020). Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07273-7"},{"key":"ref_349","first-page":"1972","article-title":"Increased UCP1 expression in the perirenal adipose tissue of patients with renal cell carcinoma","volume":"42","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1158\/0008-5472.CAN-08-0419","article-title":"Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice","volume":"68","author":"Versteeg","year":"2008","journal-title":"Cancer Res."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmet.2018.11.017","article-title":"Inhibition of Mevalonate Pathway Prevents Adipocyte Browning in Mice and Men by Affecting Protein Prenylation","volume":"29","author":"Balaz","year":"2019","journal-title":"Cell Metab."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cvr\/cvac131","article-title":"Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: Lessons from studies in mice and humans","volume":"119","author":"Ying","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_353","doi-asserted-by":"crossref","unstructured":"Atale, N., and Wells, A. (2025). Statins as Secondary Preventive Agent to Limit Breast Cancer Metastatic Outgrowth. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031300"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-023-01738-2","article-title":"Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: A systematic review and meta-analysis","volume":"22","author":"Myasoedova","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive Oxygen Species: Drivers of Physiological and Pathological Processes","volume":"13","author":"Checa","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.3390\/cimb45080420","article-title":"Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications","volume":"45","author":"Caturano","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvt013","article-title":"High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation","volume":"98","author":"Jansen","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bcp.2014.01.017","article-title":"Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes","volume":"88","author":"Kowluru","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2019.04.038","article-title":"Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target","volume":"853","author":"Peng","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1096\/fj.201600600r","article-title":"Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis","volume":"31","author":"Farnaghi","year":"2017","journal-title":"FASEB J."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.mca.0000131573.31966.34","article-title":"The antioxidant effects of statins","volume":"15","author":"Davignon","year":"2004","journal-title":"Coron. Artery Dis."},{"key":"ref_362","doi-asserted-by":"crossref","unstructured":"Vilas-Boas, E.A., Almeida, D.C., Roma, L.P., Ortis, F., and Carpinelli, A.R. (2021). Lipotoxicity and beta-Cell Failure in Type 2 Diabetes: Oxidative Stress Linked to NADPH Oxidase and ER Stress. Cells, 10.","DOI":"10.3390\/cells10123328"},{"key":"ref_363","doi-asserted-by":"crossref","unstructured":"Moon, D.O. (2023). NADPH Dynamics: Linking Insulin Resistance and beta-Cells Ferroptosis in Diabetes Mellitus. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010342"},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","article-title":"Interplay of oxidative stress, cellular communication and signaling pathways in cancer","volume":"22","author":"Iqbal","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1002\/jcp.27881","article-title":"Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways","volume":"234","author":"Hassanian","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1002\/jcp.26356","article-title":"Reactive oxygen species and colorectal cancer","volume":"233","author":"Lin","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"103285","DOI":"10.1016\/j.critrevonc.2021.103285","article-title":"Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment","volume":"160","author":"Malla","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1871520615666150518092315","article-title":"Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication","volume":"16","author":"Johar","year":"2015","journal-title":"Anticancer. Agents. Med. Chem."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-5273(02)00577-6","article-title":"A comparative study of the in vitro antioxidant activity of statins","volume":"90","author":"Franzoni","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/1871530319666190617160349","article-title":"Atorvastatin Inhibited ROS Generation and Increased IL-1beta And IL-6 Release by Mononuclear Cells from Diabetic Patients","volume":"19","author":"Volpe","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","article-title":"Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation","volume":"20","author":"Wagner","year":"2000","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_372","doi-asserted-by":"crossref","unstructured":"Xu, J.Z., Chai, Y.L., and Zhang, Y.L. (2016). Effect of rosuvastatin on high glucose-induced endoplasmic reticulum stress in human umbilical vein endothelial cells. Genet. Mol. Res., 15.","DOI":"10.4238\/gmr15048935"},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/HJH.0b013e328341cedf","article-title":"Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin","volume":"29","author":"Cheng","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdiacomp.2007.03.004","article-title":"The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose","volume":"22","author":"Piconi","year":"2008","journal-title":"J. Diabetes Complicat."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/CS20140456","article-title":"Vascular injury in diabetic db\/db mice is ameliorated by atorvastatin: Role of Rac1\/2-sensitive Nox-dependent pathways","volume":"128","author":"Callera","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000109394","article-title":"Insulin resistance, oxidative stress, and podocyte injury: Role of rosuvastatin modulation of filtration barrier injury","volume":"28","author":"DeMarco","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/en.2006-1132","article-title":"Vascular lipotoxicity: Endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats","volume":"148","author":"Chinen","year":"2007","journal-title":"Endocrinology"},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1476-511X-13-98","article-title":"Atorvastatin helps preserve pancreatic beta cell function in obese C57BL\/6 J mice and the effect is related to increased pancreas proliferation and amelioration of endoplasmic-reticulum stress","volume":"13","author":"Chen","year":"2014","journal-title":"Lipids Health Dis."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2013.01.094","article-title":"Simvastatin inhibits ox-LDL-induced inflammatory adipokines secretion via amelioration of ER stress in 3T3-L1 adipocyte","volume":"432","author":"Wu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5306\/wjco.v11.i8.573","article-title":"Statins in risk-reduction and treatment of cancer","volume":"11","author":"Barbalata","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12964-023-01359-y","article-title":"Simvastatin induces pyroptosis via ROS\/caspase-1\/GSDMD pathway in colon cancer","volume":"21","author":"Xie","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.18632\/aging.101974","article-title":"Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p","volume":"11","author":"Bai","year":"2019","journal-title":"Aging"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archinte.163.1.93","article-title":"C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: Results from the MONICA Augsburg cohort study, 1984\u20131998","volume":"163","author":"Thorand","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_384","doi-asserted-by":"crossref","unstructured":"Sproston, N.R., and Ashworth, J.J. (2018). Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00754"},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_386","doi-asserted-by":"crossref","unstructured":"Speelman, T., Dale, L., Louw, A., and Verhoog, N.J.D. (2022). The Association of Acute Phase Proteins in Stress and Inflammation-Induced T2D. Cells, 11.","DOI":"10.3390\/cells11142163"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"3706508","DOI":"10.1155\/2022\/3706508","article-title":"Role of C-Reactive Protein in Diabetic Inflammation","volume":"2022","author":"Stanimirovic","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0049-0172(95)80020-4","article-title":"Acute-phase proteins in osteoarthritis","volume":"25","author":"Sipe","year":"1995","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"e16092","DOI":"10.1016\/j.heliyon.2023.e16092","article-title":"Evaluation of C-reactive protein and fibrinogen in comparison to CEA and CA72-4 as diagnostic biomarkers for colorectal cancer","volume":"9","author":"Bu","year":"2023","journal-title":"Heliyon"},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","article-title":"Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients","volume":"27","author":"Pierce","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_391","first-page":"1289","article-title":"The acute phase response in breast carcinoma","volume":"22","author":"Lynch","year":"2002","journal-title":"Anticancer. Res."},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"35843","DOI":"10.18632\/oncotarget.8561","article-title":"Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation\/CRP evaluation (PRINCE): A randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"ref_395","doi-asserted-by":"crossref","unstructured":"Mashaba, G.R., Phoswa, W.N., and Mokgalaboni, K. (2024). The Effect of Statins on Carotid Intima-Media Thickness and C-Reactive Protein in Type 2 Diabetes Mellitus: A Meta-Analysis. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11090276"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"8732360","DOI":"10.1155\/2022\/8732360","article-title":"Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"2022","author":"Kandelouei","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"ref_397","doi-asserted-by":"crossref","unstructured":"Liu, C., Chen, H., Hu, B., Shi, J., Chen, Y., and Huang, K. (2023). New insights into the therapeutic potentials of statins in cancer. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1188926"},{"key":"ref_398","doi-asserted-by":"crossref","unstructured":"Ahmadi, M., Amiri, S., Pecic, S., Machaj, F., Rosik, J., Los, M.J., Alizadeh, J., Mahdian, R., da Silva Rosa, S.C., and Schaafsma, D. (2020). Pleiotropic effects of statins: A focus on cancer. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165968"},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12959-025-00705-z","article-title":"The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: A randomized controlled trial","volume":"23","author":"Setiawan","year":"2025","journal-title":"Thromb. J."},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ijc.30185","article-title":"Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis","volume":"139","author":"Manthravadi","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/joim.12806","article-title":"Statins: A role in breast cancer therapy?","volume":"284","author":"Borgquist","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/acs.biochem.0c00476","article-title":"Hepatocellular Carcinoma and Statins","volume":"59","author":"Trezeguet","year":"2020","journal-title":"Biochemistry"},{"key":"ref_403","doi-asserted-by":"crossref","unstructured":"Soulaidopoulos, S., Nikiphorou, E., Dimitroulas, T., and Kitas, G.D. (2018). The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00024"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/acr.21643","article-title":"Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: A population-based study","volume":"64","author":"Choi","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2017.10.013","article-title":"The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials","volume":"17","author":"Li","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1002\/art.20673","article-title":"Assessment of the efficacy of different statins in murine collagen-induced arthritis","volume":"50","author":"Palmer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/rheumatology\/kez471","article-title":"A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis","volume":"59","author":"Aranow","year":"2020","journal-title":"Rheumatology"},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_410","doi-asserted-by":"crossref","unstructured":"de Oliveira, P.S.S., da Paixao, A.B.F., da Rocha Junior, L.F., Branco Pinto Duarte, A.L., Pereira, M.C., Barreto de Melo Rego, M.J., da Rocha Pitta, I., and da Rocha Pitta, M.G. (2020). Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis. Immunobiology, 225.","DOI":"10.1016\/j.imbio.2020.151908"},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1194\/jlr.M010876","article-title":"Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis","volume":"52","author":"Tang","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"50","author":"Booth","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1097\/MD.0000000000000572","article-title":"Effect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: A meta-analysis","volume":"94","author":"Xing","year":"2015","journal-title":"Medicine"},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2125.2009.03560.x","article-title":"Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database","volume":"69","author":"Lodi","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-nutr-071811-150709","article-title":"New roles of HDL in inflammation and hematopoiesis","volume":"32","author":"Zhu","year":"2012","journal-title":"Annu. Rev. Nutr."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"100252","DOI":"10.1016\/j.clinsp.2023.100252","article-title":"Effects of atorvastatin in suppressing pulmonary vascular remodeling in rats with chronic obstructive pulmonary disease","volume":"78","author":"He","year":"2023","journal-title":"Clinics"},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.curtheres.2009.10.003","article-title":"Effects of atorvastatin on smoking-induced alveolar injury in rat lungs","volume":"70","author":"Yildiz","year":"2009","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_418","first-page":"111","article-title":"Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study","volume":"66","author":"Mroz","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.amjmed.2013.01.036","article-title":"Statin use and risk of COPD exacerbation requiring hospitalization","volume":"126","author":"Wang","year":"2013","journal-title":"Am. J. Med."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pupt.2012.10.008","article-title":"Statins, systemic inflammation and risk of death in COPD: The Rotterdam study","volume":"26","author":"Lahousse","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_421","doi-asserted-by":"crossref","unstructured":"Cao, C., Wu, Y., Xu, Z., Lv, D., Zhang, C., Lai, T., Li, W., and Shen, H. (2015). The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: A systematic review and meta-analysis of observational research. Sci. Rep., 5.","DOI":"10.1038\/srep16461"},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jnim.2016.04.006","article-title":"Rosuvastatin, lycopene and omega-3 fatty acids: A potential treatment for systemic inflammation in COPD; a pilot study","volume":"5","author":"Williams","year":"2016","journal-title":"J. Nutr. Intermed. Metab."},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/eci.12461","article-title":"The role of mitochondria in statin-induced myopathy","volume":"45","author":"Apostolopoulou","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"104201","DOI":"10.1016\/j.phrs.2019.03.010","article-title":"Mechanisms of statin-associated skeletal muscle-associated symptoms","volume":"154","author":"Bouitbir","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40264-024-01413-9","article-title":"The Role of Mitochondria in Statin-Induced Myopathy","volume":"47","author":"Bell","year":"2024","journal-title":"Drug Saf."},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: A review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_427","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13219","article-title":"Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: The PROSISA Study","volume":"290","author":"Casula","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: Impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_429","doi-asserted-by":"crossref","first-page":"101749","DOI":"10.1016\/j.beem.2023.101749","article-title":"Statins and diabetes: What are the connections?","volume":"37","author":"Sattar","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_430","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa1403086","article-title":"Simvastatin for the prevention of exacerbations in moderate-to-severe COPD","volume":"370","author":"Criner","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_431","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1874467209666160112125911","article-title":"Clinical Studies of Statins in Asthma and COPD","volume":"10","author":"Thomson","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1940-6207.CAPR-10-0215","article-title":"Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention","volume":"4","author":"Limburg","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_433","doi-asserted-by":"crossref","unstructured":"Momeni, B., Nazer, S., Masoompour, S.M., Geramizadeh, B., and Sajadi, S.V. (2021). The effect of atorvastatin on inflammatory markers in sulfur mustard gas induced bronchitis: A randomized double-blinded, placebo-control clinical trial. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01481-y"},{"key":"ref_434","first-page":"540","article-title":"Evaluation of the Anti-inflammatory Activity of Atorvastatin and its Effect on Alveolar Diameter in a Model of Elastase-induced Emphysema in Rats","volume":"65","author":"Boiati","year":"2015","journal-title":"Drug Res."},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.joca.2020.04.007","article-title":"Association between statin use and incidence or progression of osteoarthritis: Meta-analysis of observational studies","volume":"28","author":"Wang","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4078\/jrd.2023.0021","article-title":"Rosuvastatin treatment alone cannot alleviate lupus in murine model: A pilot study","volume":"30","author":"Baek","year":"2023","journal-title":"J. Rheum. Dis."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijcard.2015.03.373","article-title":"Rosuvastatin and risk of acute pancreatitis in a population-based case-control study","volume":"187","author":"Lai","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_438","doi-asserted-by":"crossref","unstructured":"Berk, M., Mohebbi, M., Dean, O.M., Cotton, S.M., Chanen, A.M., Dodd, S., Ratheesh, A., Amminger, G.P., Phelan, M., and Weller, A. (2020). Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): A randomised clinical trial of rosuvastatin and aspirin. BMC Med., 18.","DOI":"10.1186\/s12916-019-1475-6"},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40262-016-0462-8","article-title":"Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis","volume":"56","author":"Lee","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"ref_440","first-page":"e15075","article-title":"Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial","volume":"34","author":"Ghiasi","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/01635581.2012.695424","article-title":"Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation","volume":"64","author":"Guan","year":"2012","journal-title":"Nutr. Cancer"},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/jrpp.JRPP_17_93","article-title":"Trial of Atorvastatin on Serum Interleukin-6, Total Antioxidant Capacity, C-Reactive Protein, and Alpha-1 Antitrypsin in Patients with Chronic Obstructive Pulmonary Disease","volume":"7","author":"Arian","year":"2018","journal-title":"J. Res. Pharm. Pract."},{"key":"ref_443","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Emberson, J.R., Kearney, P.M., Blackwell, L., Newman, C., Reith, C., Bhala, N., Holland, L., Peto, R., and Keech, A. (2012). Lack of effect of lowering LDL cholesterol on cancer: Meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029849"},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"djv045","DOI":"10.1093\/jnci\/djv045","article-title":"Statin use and survival after colorectal cancer: The importance of comprehensive confounder adjustment","volume":"107","author":"Hoffmeister","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cgh.2012.08.037","article-title":"Statins and colorectal cancer","volume":"11","author":"Lochhead","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_446","first-page":"CD011959","article-title":"Statins versus placebo for people with chronic obstructive pulmonary disease","volume":"7","author":"Walsh","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"e35088","DOI":"10.1097\/MD.0000000000035088","article-title":"The efficacy of statins in the treatment of rheumatoid arthritis: A systematic review and meta-analysis","volume":"102","author":"Ren","year":"2023","journal-title":"Medicine"},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: Meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-019-1099-z","article-title":"Long-term statin persistence is poor among high-risk patients with dyslipidemia: A real-world administrative claims analysis","volume":"18","author":"Toth","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_450","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amjmed.2021.09.014","article-title":"Statin Intolerance and Noncompliance: An Empiric Approach","volume":"135","author":"Grundy","year":"2022","journal-title":"Am. J. Med."},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12935-023-02890-1","article-title":"Paradoxical effects of statins on endothelial and cancer cells: The impact of concentrations","volume":"23","author":"Ahmadi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_452","doi-asserted-by":"crossref","unstructured":"Climent, E., Benaiges, D., and Pedro-Botet, J. (2021). Hydrophilic or Lipophilic Statins?. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.687585"},{"key":"ref_453","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s11606-021-06651-6","article-title":"The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: An Observational Cohort Study","volume":"36","author":"Mueller","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.phrs.2017.09.013","article-title":"The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis","volume":"128","author":"Irwin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10557-022-07405-0","article-title":"Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials","volume":"38","author":"Hou","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"e2113186","DOI":"10.1001\/jamanetworkopen.2021.13186","article-title":"Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy","volume":"4","author":"Rea","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ehjcvp\/pvaa010","article-title":"Low adherence to statin treatment during the 1st year after an acute myocardial infarction is associated with increased 2nd-year mortality risk-an inverse probability of treatment weighted study on 54 872 patients","volume":"7","author":"Khalaf","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4254\/wjh.v8.i22.924","article-title":"Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications","volume":"8","author":"Nemes","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"11795514241231533","DOI":"10.1177\/11795514241231533","article-title":"Co-Morbid Hypothyroidism and Liver Dysfunction: A Review","volume":"17","author":"Yorke","year":"2024","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_460","doi-asserted-by":"crossref","unstructured":"Duntas, L.H., and Brenta, G. (2018). A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00511"},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1089\/thy.2020.0715","article-title":"Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis","volume":"31","author":"Scappaticcio","year":"2021","journal-title":"Thyroid"},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"790458","DOI":"10.1155\/2014\/790458","article-title":"Grave\u2019s Disease with Severe Hepatic Dysfunction: A Diagnostic and Therapeutic Challenge","volume":"2014","author":"Bhuyan","year":"2014","journal-title":"Case Rep. Med."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"11795514221074672","DOI":"10.1177\/11795514221074672","article-title":"Hyperthyroidism and Liver Dysfunction: A Review of a Common Comorbidity","volume":"15","author":"Yorke","year":"2022","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3923\/jbs.2013.665.678","article-title":"Liver Functional Behavior During Thyrotoxicosis: A Review","volume":"13","author":"Mansourian","year":"2013","journal-title":"J. Biol. Sci."},{"key":"ref_465","unstructured":"L\u00f3pez-Castro, J., and Cid-Conde, L. (2020). Pharmacokinetic Aspects of Statins. Cardiovascular Risk Factors in Pathology, IntechOpen."},{"key":"ref_466","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/pgs.09.42","article-title":"Statin regulation of CYP3A4 and CYP3A5 expression","volume":"10","author":"Willrich","year":"2009","journal-title":"Pharmacogenomics"},{"key":"ref_467","unstructured":"Corticosteroids (2012). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1210\/jc.2019-00530","article-title":"Association Between Statin Use and Sex Hormone in the Multi-Ethnic Study of Atherosclerosis Cohort","volume":"104","author":"Oluleye","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lipd.12399","article-title":"Effects of high-intensity statin therapy on steroid hormones and vitamin D in type 2 diabetic men: A prospective self-controlled study","volume":"59","author":"Chihaoui","year":"2024","journal-title":"Lipids"},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/s1677-5538.ibju.2023.0578","article-title":"Do statins decrease testosterone in men? Systematic review and meta-analysis","volume":"50","author":"Glina","year":"2024","journal-title":"Int. Braz. J. Urol."},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.medcli.2021.06.018","article-title":"Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study","volume":"158","author":"Trias","year":"2022","journal-title":"Med. Clin."},{"key":"ref_472","unstructured":"Chacko, S.M., and Thekkekara, P.T. (2021). Combined Effect of Metformin and Statin. Metformin\u2014Pharmacology and Drug Interactions, IntechOpen."},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"e007280","DOI":"10.1136\/bmjopen-2014-007280","article-title":"An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: A meta-analysis of randomised controlled trials","volume":"5","author":"Sun","year":"2015","journal-title":"BMJ Open"},{"key":"ref_474","first-page":"e30351","article-title":"Insulin Resistance in Polycystic Ovarian Syndrome","volume":"14","author":"Purwar","year":"2022","journal-title":"Cureus"},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40618-018-0949-2","article-title":"Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome","volume":"42","author":"Mu","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/dc19-1828","article-title":"Epigenetic Link Between Statin Therapy and Type 2 Diabetes","volume":"43","author":"Nano","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_477","doi-asserted-by":"crossref","first-page":"e22566","DOI":"10.1002\/jcla.22566","article-title":"Influence of 6 genetic variants on the efficacy of statins in patients with dyslipidemia","volume":"32","author":"Pinto","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: A genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref_479","doi-asserted-by":"crossref","unstructured":"Preissner, S.C., Hoffmann, M.F., Preissner, R., Dunkel, M., Gewiess, A., and Preissner, S. (2013). Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082562"},{"key":"ref_480","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0009-9236(01)25429-0","article-title":"Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin","volume":"70","author":"Mulder","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_481","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/gim.2014.41","article-title":"Genetic factors affecting statin concentrations and subsequent myopathy: A HuGENet systematic review","volume":"16","author":"Canestaro","year":"2014","journal-title":"Genet. Med."},{"key":"ref_482","doi-asserted-by":"crossref","unstructured":"Zheng, E., Madura, P., Grandos, J., Broncel, M., Pawlos, A., Wozniak, E., and Gorzelak-Pabis, P. (2024). When the same treatment has different response: The role of pharmacogenomics in statin therapy. Biomed. Pharmacother., 170.","DOI":"10.1016\/j.biopha.2023.115966"},{"key":"ref_483","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/1060028020934879","article-title":"Geosocial Factors Associated With Adherence to Statin Medications","volume":"54","author":"Erickson","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_484","doi-asserted-by":"crossref","unstructured":"Boruzs, K., Juhasz, A., Nagy, C., Adany, R., and Biro, K. (2016). Relationship between Statin Utilization and Socioeconomic Deprivation in Hungary. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00066"},{"key":"ref_485","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2125.2005.02494.x","article-title":"Socioeconomic gradient in use of statins among Danish patients: Population-based cross-sectional study","volume":"60","author":"Thomsen","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_486","doi-asserted-by":"crossref","first-page":"e24120","DOI":"10.1016\/j.heliyon.2024.e24120","article-title":"Integrating network pharmacology and experimental verification to decipher the multitarget pharmacological mechanism of Cinnamomum zeylanicum essential oil in treating inflammation","volume":"10","author":"Mohanty","year":"2024","journal-title":"Heliyon"},{"key":"ref_487","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1194\/jlr.RA120001006","article-title":"Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase","volume":"61","author":"Jarrett","year":"2020","journal-title":"J. Lipid Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8429\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:40Z","timestamp":1760034940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":487,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178429"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178429","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}